Of the eight validated fusions, two were predicted to be in-frame (SLC2A1–FAF1 and BCAS4–AURKA) and were both present in a single tumour (ie MPC10; Figure 2 and Supplementary Figure 3). The gene discussed is AURKA; the disease is neoplasm.